Literature DB >> 11577779

Mechanism of permissive prostacyclin action in cerebrovascular smooth muscle.

C W Leffler1, L Balabanova.   

Abstract

Prostacyclin permissively allows increased cAMP and cerebral vasodilation to hypercapnia in piglets. The prostacyclin receptor (IP) is coupled to phospholipase C (PLC) in piglet cerebral microvascular smooth muscle cells (SMC). We hypothesize that inhibition of PLC blocks the permissive action of IP receptor agonist, iloprost, and direct activation of PKC substitutes for the IP receptor agonist in SMC. SMC cAMP production was measured at normal pHi/pHo and with reduced pHi/pHo in the absence and presence of iloprost (100 pM). Half of the cells were pretreated with U73122, the PLC inhibitor, which decreased the basal IP3 and blocked the increase in IP3 caused by iloprost. Without iloprost, decreasing pHi/pHo increased cAMP production (40%). With iloprost, the cAMP response to acidosis increased to over 80%. U73122 prevented accentuation of the cAMP response by iloprost. Phorbol myristate acetate augmented the response to acidosis similarly to iloprost. These data suggest IP agonists augment the cAMP response to acidosis via coupling through PLC to activate PKC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577779     DOI: 10.1016/s0090-6980(01)00153-8

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  2 in total

1.  Arachidonic acid- and prostaglandin E2-induced cerebral vasodilation is mediated by carbon monoxide, independent of reactive oxygen species in piglets.

Authors:  Alie Kanu; Charles W Leffler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-07       Impact factor: 4.733

2.  Regional Differences in the Neuronal Expression of Cyclooxygenase-2 (COX-2) in the Newborn Pig Brain.

Authors:  Orsolya Oláh; István Németh; Valéria Tóth-Szűki; Ferenc Bari; Ferenc Domoki
Journal:  Acta Histochem Cytochem       Date:  2012-05-15       Impact factor: 1.938

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.